• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

What's the deal with all the Takeda managers coming to Novo?





Your partners will be expert sample droppers too! A ton of actively employed Takeda reps were at the Phoenix interviews this week. Novo seems to have a thing for them. Good luck with that one!